Form 4 for EDIT Editas Medicine, Inc.
Accepted 2023-02-15 00:00:00 ET · period of report 2023-02-13 · accession 0001415889-23-002604 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-15 | 2023-02-13 | EDIT | Shearman Mark S | EVP, CSO | S - Sale | $9.67 | -2,790 | 65.6K | -4% | -$27.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-13 | S | D | 2,790 | $9.67 | 65,559 | D | — | — |